Printer Friendly



Keywords: Infertility, oligomenorrhea, secondary amenorrhea, reproductive hormones, hormonal imbalance.


Fertility is given due attention in all societies. The inability to have children has traditionally been a source of pain, anxiety and shame, flagging the worse consequences to infertile couples.1 Infertility is one of the main gynecological problems and is defined as failure to conceive after 1 year of normal, unprotected marital relations. It is classified as primary infertility if no previous pregnancy has occurred and secondary infertility if it occurred after one or more pregnancies.2 Approximately 15 % of couples attempting their first pregnancy face primary infertility and another 10% face secondary infertility.2,3 Many causes of infertility have been established.

Endocrinology studies on female infertility have brought to limelight problems of anovulatory cycle and hyperprolactinemia. Ovulation depends on a number of factors, including complex interactions among hormones secreted from the brain, the pituitary gland and the ovary after reproductive maturity.1 During the menstrual cycle, the concentrations of hormones change dramatically resulting in ovulation and preparation of the uterus for implantation of the fertilized egg. If this highly orchestrated and tightly controlled sequence of events is interrupted, it may result into infertility or reduced fertility.4 Measurement of peptide and steroid hormones in serum, play a key role in investigation and treatment of female reproductive problems.5

Proper testing differs broadly according to the clinical picture, physical findings and results of other diagnostic procedures. Generally the most important hormones measured are LH, FSH, Prolactin and a variety of steroid hormones such as Estrogens, Progesterones and Androgens.


This is a retrospective study, carried out from January 2013 to August 2013 at National Health Research Complex, Shaikh Zayed Hospital, Lahore, Pakistan. Females who were registered in Gynecology and Obstetrics department of Shaikh Zayed Hospital for infertility (either primary or secondary), oligomenorrhea and secondary amenorrhea and underwent hormonal assessment at NHRC immunoassay laboratory, from January 2010 to December 2012 were included in the study. Females with hypomenorrhea, polymenorrhea, primary amenorrhea and gestational amenorrhea were excluded from the study (due to very small number of patients in each group).

After the approval of Ethical Review Board of Shaikh Zayed Medical Complex, demographic information including clinical presentation, age, hormone levels and diagnosis (including pelvic scans) were extracted from medicalhistory files of patients (available at record room of Gynae and Obs. department) and NHRC immunoassay laboratory data, and recorded on prescribed study proforma.

Primary infertility was considered when a patient has never been able to conceive a pregnancy in spite of unprotected marital relations, for a period of 1 year at least. Secondary infertility is failing to conceive, following a single previous pregnancy in presence of normal, unprotected marital relations. Oligomenorrhea was defined as irregular or infrequent menstrual periods with intervals of more than 6 weeks. Secondary amenorrhea was considered when menstruation has previously occurred but then stopped for a period of [greater than or equal to] 6 consecutive months.

Venous blood samples (5 ml) were collected on 2nd day of cycle, for determination of reproductive hormone levels. Hormone levels were quantified in serum samples, using commercially available (enzyme immunoassay) kits from Biocheck USA. All assays were performed by a trained technician, according to manufacturer's instructions. Analysis of the assays was carried out on Anthox 2010 plate reader using softmax statistical package. For analytical accuracy of results all assays were performed with 6-7 standards and 3 quality control pools (Biorad USA) in each assay batch.

Data Analysis

Data was analyzed using statistical package for social sciences version 17.0. Hormone levels were reported as Mean +- Standard error of mean while Mann Whitney U test was used to test for differences in hormone levels between hormonal imbalance and no hormonal imbalance subgroups, value of P a$? 0.05 was considered as statistically significant.


During the retrospective study period, medical-history files of 257 females were available; out of those complete information, as per study proforma, was available for 229 females including clinical histories, hormone profiles and pelvic scans. Twenty eight females with incomplete clinical histories were excluded from the study. Age of study participants ranged between 14-40 years (Table 1). Out of 229 females, 101 (44.1%) presented with hormonal imbalance whereas 128 (55.9%) had no hormonal imbalance. Frequency of different gynecological conditions was primary infertility 91 (39.74%), secondary infertility 61 (26.63%), oligomenorrhea 43 (18.78%) and secondary amenorrhea 34 (14.85%) (Fig. 1).

Table 1: Age distribution of study participants.

###No. of

Condition###Age (Years)###%age


###18 - 24###24###26.37

Primary infertility###25 - 31###48###52.74

###32 - 36###19###20.87

###19 - 24###10###16.4


###25 - 31###32###52.45


###32 - 38###19###31.14

###14 - 23###23###53.48

Oligomenorrhea###25 - 31###14###32.55

###32 - 40###06###13.95

###14 - 24###09###26.47


###25 - 31###17###50.0


###32 - 38###08###23.52

Table 2: Level of LH, FSH and Prolactin in females with hormonal imbalance and no hormonal imbalance sub groups.


###Condition###LH (mIU/ml)###P value###P value###P value


Primary Infertility

Hormonal cause (n = 29)###20.15 +- 4.3###19.7 +- 5.5###492 +- 44.1


No hormonal cause (n = 56)###7.6 +- 0.5###5.5 +- 0.23###334 +- 17.1

Secondary Infertility

Hormonal cause (n = 17)###16.8 +- 3.8###11.3 +- 2.1###464 +- 92.4


No hormonal cause (n = 41)###8.1 +- 0.64###5.3 +- 0.28###287 +- 20.7


Hormonal cause (n = 19)###16.9 +- 3.5###18.9 +- 5.3###619 +- 136


No hormonal cause (n = 20)###8.4 +- 0.82###6.05 +- 0.59###322 +- 26

Secondary Amenorrhea

Hormonal cause (n = 19)###25.63 +- 4.2###21.5 +- 6.6###703 +- 118.0


No hormonal cause (n = 11)###6.49 +- 0.77###5.34 +- 0.64###306 +- 27.0

LH and FSH levels were found to be elevated in majority of females with hormonal imbalance (Table 2). Elevation was more in females with secondary amenorrhea followed by primary infertility. Mean prolactin level was found to be the highest in females with secondary amenorrhea followed by females with oligomenorrhea (Table 2).

Major proportion of infertile females presented with PCOS and hyperprolactinemia; followed by premature ovarian failure, hirsuitism and resistance ovarian syndrome, respectively (Figure 2). Main presentations of females with oligomenorrhea were hirsutism and PCOS and of secondary amenorrhea were hyperprolactinemia and premature ovarian failure (Figure 3).

In case of primary infertility, LH level (1.63 +- 0.141 mIU/ml) of 2 females in the hormonal imbalance subgroup (n = 34) was lower than the normal cut off level (2 mIU/ml). Mean LH level of rest of females in this sub-group was significantly elevated (p = 0.0047) as compared to females with no hormonal imbalance sub-group. FSH level of 4 females was lower (0.857 +- 0.579 mIU/ml) than cut off level (2 mIU/ml) in hormonal imbalance sub-group. Remaining females had significantly elevated (p = 0.016) mean FSH level. Mean prolactin level was significantly elevated (p = 0.0017) in females with hormonal imbalance (Table 2).

Among females of secondary infertility, in hormonal imbalance subgroup, 2 females had low LH (1.6 +- 0.346 mIU/ml) and 3 had low FSH level (1.3 +- 0.529 mIU/ml) than cut off level, whereas remaining females of this subgroup had significantly elevated mean LH (p = 0.04) and mean FSH levels (p = 0.015) as compared to females in no hormonal imbalance subgroup. Mean prolactin level (464+- mIU/ml) was also significantly elevated (p = 0.039) in females with hormonal imbalance (Table 2).

In females with oligomenorrhea, LH level (1.7 mIU/ml) of 1 female and FSH level (1.15 +- 0.265 mIU/ ml) of 3 females were found lower than normal cut off levels whereas remaining females in this subgroup had significantly high mean LH (p = 0.0344), mean FSH (p = 0.018) and mean prolactin levels (p = 0.044) as compared to the females in no hormonal imbalance subgroup (Table 2).

Among females with secondary amenorrhea, four females in hormonal imbalance subgroup had low levels of FSH (1.4+-0.36 mIU/ml) and one female among those 4, also had low LH level (1.7 +- mIU/ml) than the normal cut off. Remaining females in this subgroup had significantly high mean LH (p = 0.0002) and mean FSH levels (p = 0.027). In this subgroup mean prolactin level (703 +- mIU/ml) was significantly higher (p = 0.0034) as compared to the females in no hormonal imbalance group (Table 2).


Hormonal imbalance is one of the major causes of infertility and amenorrhea and results from dysfunction of hypothalamic-pituitary-gonadal axis, due to stress, environmental factors and diet (in case of hirsuitism). In the current study, 101 (44.1%) of the females showed evidence of hypothalamic-pituitary-gonadal axis dysfunction based on serum levels of LH, FSH and prolactin. A study carried out in Nigeria reported incidence of 58% hormonal imbalance in infertile females.6 This variability could be due to different sets of studied population and geographical locations.

Results of the present study showed that majority of females with hormonal imbalance had increase in gonadotrophins concentrations (serum LH and FSH). These results are consistent with the studies done by Adegoke et al7 and Braide et al.1 Hyper secretion of LH is associated with menstrual cycle disturbances and infertility. It is this endocrine feature that result in reduced conception rates and increased rate of miscarriages in both natural and assisted conception.8 FSH levels are elevated in resistance ovarian syndrome and premature ovarian failure.1 Moreover, in this study some females with hormonal imbalance also had low serum levels of LH and FSH, which is consistent with a Nigerian study conducted by Eniola et al.9 This shows that both high and low levels of gonadotrophins can be the cause of female infertility and menstrual cycle iregularities.

In the present study frequency of PCOS in infertile women (primary and secondary combined) was found to be 38.18% while two studies done in Pakistan reported prevalence of PCOS as 40.9%10 and 28%,11 respectively. The frequency of hyperprolactinemia as the cause of female infertility was reported to be 28% by Eniola et al.9 25% by Mishra et al. 12, 19% by Onyenekwe et al.6 and 18% by Kumkum et al.13, however in the present study the frequency was found to be 30.9%. All subjects in this category had serum Prolactin level above 666 mIU/L (Normal range: 66-666 mIU/L).

In humans hyperprolactinemia is associated with a marked reduction in both the frequency and amplitude of LH pulses,14 indirectly suggesting that both the brain and pituitary might be targets for prolactin.1 The increase observed in prolactin may be the cause of low estrogen and progesterone concentration in the infertile females.1 In vitro increase in prolactin level inhibits progesterone secretion in human porcine granulose cells.15 A study demonstrated that high levels of prolactin, inhibit follicular steroidogenesis not only by interfering with aromatase activity but also by reducing the production by the theca of the androgen precursors necessary for oestrogen production.1

Oligomenorrhea can be a result of prolactinomas. It may also be caused by thyrotoxicosis, hormonal changes, PCOS and Graves disease. The main causes of oligomenorrhea in the present study were PCOS (34.78%) and hyperprolactinemia (21.73%). A study demonstrated that females with PCOS patients are more likely to present with oligomenorrhea (76%) as compared to amenorrhea (24%).16

The three most common causes of secondary amenorrhea seen in the current study were hyperprolactinemia (30.43%), premature ovarian failure (26.08%) and PCOS (21.73%). A study elsewhere has shown an approximate frequency of 14% hyperprolactinemia and 12% premature ovarian failure in secondary amenorrhea patients.17 An Indian study reported premature ovarian failure is the aetiology in 10%-28% of the cases with primary amenorrhea and in 4%-18% of those with secondary amenorrhea.18

It is concluded that this study highlights the importance of role of pituitary gonadotrophins in management of infertility and oligo/amenorrhea. This study also shows that incidence of hormonal imbalance is on rise in women of reproductive age and is becoming a major cause of infertility and menstrual disorders.


Researchers of the study are extremely thankful to Professor Dr. Saeed, Head Department of Gynecology and Obstetrics, Shaikh Zayed Hospital, Lahore, for providing support and assistance for conducting the study. Researchers are also thankful to staff of record room of Department of Gynae and Obs. for their help and cooperation.

Author's Contributions:

SN: Design of study, data collection, data analysis, writing first draft of article, final approval from all authors. FG: Data analysis, review of draft article, final approval of article to be submitted. SM: Acquisition and interpretation of data, review of draft article, final approval of article to be submitted.

Conflict of Interest

All authors declare no conflict of interest


Approved by PMRC (Funds were not requested).

Foot Line

Reproductive hormones in infertility/menstrual disorders.


1. Braide AS. Gonadotrophic hormones, progesterone and prolactin levels among infertile women attending university of Port Harcourt teaching hospital. Eur J Sci Res. 2011; 57 (2): 336-372.

2. Shaban SF. Male infertility overview: assessment, diagnosis and treatment. In Georgia Reproductive Specialist. Available at: Accessed on 11-9-2013.

3. Vaidya D. the hormonal assessment of the infertile male. In: A publication of the hope infertility clinic. Available at: education. Accessed on 16-92013.

4. Speroff L. Female infertility. In: Speroff L, Glass RH, Kase NG, eds. Clinical gynecologic endocrinology and infertility. 6th ed. Lippincot, Williams and Wilkins, Philadelphia, 1994.

5. Nanji AA. Disorders of gonadal function. Clin Lab Med. 1984; 4: 717-28.

6. Onyenekwe CC, Meludu SC, Dioka CE. Abnormal reproductive hormone profiles amongst infertile married women attending fertility support laboratory. J bio investi. 2005; 3 (1): 26-30.

7. Adegoke, OA. Bamigbowu, EO, Ayodele, MBO, Emisibe, SC. Serum Follicle stimulating hormone and Luteinizing hormone levels in primary and secondary infertile women in Port Harcourt. J Nigerian Bio Sci. 2007; 3 (4): 19-21.

8. Balen A, Michelmore K. What is polycystic ovary syndrome? Are national views important? Hum Reprod. 2002; 17 (9): 2219-27.

9. Eniola WO, Olufemi AA, Adetola AA, et al. Pattern of reproductive hormones (Follicle stimulating hormone, Luteinizing hormone, Estradiol, Progesterone and Prolactin) levels in infertile women in Sagamu South Western Nigeria. Der Pharmacia Lettre, 2012; 4 (2): 549553.

10. Baqai Z, Khanam M, Parveen S. Prevalence of polycystic ovarian syndrome in infertile patients. Medical channel, 2010; 16 (3): 437-440.

11. Sultana A, Nadir S. Pituitary gonadotrophic hormones in women with oligo/amenorrhea. J Ayub Med Coll. 2008; 20 (3): 62-65.

12. Mishra R, Baveja R, Gupta V, et al. Prolactin level in infertility with menstrual irregularities. J Obstet Gynecol India, 2002; 52: 40-3.

13. Kumkum A, Jasmine K, Shweta G, Ajeshwar PN. Hyperprolactinema and its correlation with hypothyroidism in Infertile women. J Obstet Gynecol India, 2006; 56: 68-71.

14. Matsuzaki T, Azuma K, Irahara M, Yasui T, Aono T. Mechanism of anovulation in hyperprolactinemic amenorrhea determined by pulsatile gonadotropin-releasing hormone injection combined with human chorionic gonadotropin. Fertil Steril. 1994; 62 (6): 1143-9.

15. Mc Neilly AS, Glasier A, Jonassen J, Howeic PW. Evidence for a direct inhibition of ovarian function by prolactin. Journal of Reproductive Fertility, 1982; 65: 559-569.

16. Bili H, Laven J, Imani B, Eijkemans MJ, Fauser BC. Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligoamenorrhoeic infertile women of reproductive years. Eur J Endocrinol. 2001; 145 (6): 749-55.

17. Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients. Am J Obstet Gynecol. 1986; 155 (3): 531-43.

18. Goswami D, Conway GS. Premature ovarian failure. Human Reproduction Update, 2005; 11 (4): 391-410.
COPYRIGHT 2018 Knowledge Bylanes
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Date:Sep 30, 2018

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |